Humacyte (NASDAQ:HUMAW) Trading Up 0.6% – Here’s Why

Humacyte, Inc. (NASDAQ:HUMAWGet Free Report)’s share price was up 0.6% on Friday . The stock traded as high as $0.90 and last traded at $0.89. Approximately 13,050 shares were traded during trading, a decline of 7% from the average daily volume of 14,034 shares. The stock had previously closed at $0.88.

Humacyte Stock Performance

The firm’s 50 day moving average is $1.34 and its two-hundred day moving average is $1.62.

About Humacyte

(Get Free Report)

Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection.

Featured Articles

Receive News & Ratings for Humacyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humacyte and related companies with MarketBeat.com's FREE daily email newsletter.